data_2f3a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2f3a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.611 ' C ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.535 ' N ' HD12 ' A' ' 2' ' ' LEU . 56.8 m-85 -85.35 -29.33 24.56 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.976 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -47.44 -22.54 0.46 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.447 ' N ' ' C ' ' A' ' 3' ' ' PHE . 17.8 ttmt -87.48 -34.67 18.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.842 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -67.94 -16.58 21.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.047 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.695 ' CB ' HH11 ' A' ' 7' ' ' ARG . 0.0 OUTLIER -82.01 -48.32 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.592 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -51.09 -51.35 54.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.678 ' CG2' ' CE2' ' A' ' 13' ' ' PHE . 7.6 p -49.62 -47.37 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 6' ' ' ILE . 48.7 mm -44.69 -36.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -54.85 -35.87 64.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 9' ' ' VAL . 5.1 tmtm? -83.82 -30.08 26.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.291 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.784 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 32.5 p90 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.315 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.604 ' C ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.434 0 CA-C-O 120.775 0.321 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.584 ' N ' HD13 ' A' ' 2' ' ' LEU . 52.4 m-85 -86.29 -29.08 23.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.082 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -48.47 -21.79 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.458 ' N ' ' C ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -87.55 -30.88 20.21 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.898 179.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -74.3 -18.1 16.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.526 ' CG ' HH11 ' A' ' 7' ' ' ARG . 1.4 ttt-85 -83.87 -49.97 8.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.55 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -49.15 -48.29 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.805 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.607 ' CG2' ' CE1' ' A' ' 13' ' ' PHE . 7.2 p -51.14 -49.05 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 10' ' ' ILE . 47.6 mm -44.92 -32.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -56.23 -35.68 67.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 9' ' ' VAL . 57.4 tttp -86.46 -29.64 22.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.593 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.708 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 50.2 p90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.395 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.622 HD11 ' N ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.377 0 CA-C-O 120.576 0.227 . . . . 0.0 111.06 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.622 ' N ' HD11 ' A' ' 2' ' ' LEU . 51.0 m-85 -86.52 -28.14 23.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.306 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.28 -21.19 1.28 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 3' ' ' PHE . 23.1 ttmt -87.54 -25.15 23.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.909 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -85.54 -20.27 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.244 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.17 -42.7 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.881 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -61.65 -41.14 97.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.489 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 12' ' ' LYS . 7.4 p -56.94 -50.42 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.159 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 13' ' ' PHE . 1.5 mp -44.99 -36.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.256 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -52.73 -30.71 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.664 ' N ' ' O ' ' A' ' 9' ' ' VAL . 29.7 ttmt -88.03 -29.57 20.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.347 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.704 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 54.9 p90 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.506 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.616 ' C ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.442 0 CA-C-O 120.672 0.272 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 6' ' ' ILE . 57.9 m-85 -85.84 -29.5 23.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.495 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -21.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.472 ' N ' ' C ' ' A' ' 3' ' ' PHE . 38.4 tttm -87.53 -29.7 21.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.833 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.57 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -78.91 -24.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.168 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -83.77 -51.43 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.472 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -48.04 -46.7 33.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.794 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.568 ' CG2' ' CE1' ' A' ' 13' ' ' PHE . 7.9 p -51.34 -50.02 29.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.727 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 45.2 mm -44.85 -35.06 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.529 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -54.23 -36.42 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' VAL . 27.3 ttpt -86.79 -28.17 23.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.62 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.728 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 46.9 p90 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.456 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.613 ' C ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.465 0 CA-C-O 120.744 0.307 . . . . 0.0 110.698 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.578 ' N ' HD11 ' A' ' 2' ' ' LEU . 53.0 m-85 -86.44 -28.12 23.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.948 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -50.55 -19.95 1.04 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.46 ' N ' ' C ' ' A' ' 3' ' ' PHE . 29.5 ttmt -87.52 -28.64 21.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.454 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -83.59 -25.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.135 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.668 ' CG ' HH11 ' A' ' 7' ' ' ARG . 0.3 OUTLIER -83.6 -52.39 6.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -49.26 -46.55 46.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.883 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.63 ' CG2' ' CZ ' ' A' ' 13' ' ' PHE . 11.2 p -50.0 -48.81 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.489 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.467 ' HA ' ' C ' ' A' ' 13' ' ' PHE . 38.5 mm -46.91 -39.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -53.26 -33.39 52.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' VAL . 28.5 tttm -87.33 -28.95 21.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.354 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 54.9 p90 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.477 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 4' ' ' ASP . 12.9 mmt180 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.611 ' C ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -46.07 -17.4 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.535 ' N ' HD12 ' A' ' 2' ' ' LEU . 56.8 m-85 -85.35 -29.33 24.56 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.976 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 1' ' ' ARG . 41.7 m-20 -47.44 -22.54 0.46 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' N ' ' C ' ' A' ' 3' ' ' PHE . 17.8 ttmt -87.48 -34.67 18.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.842 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -67.94 -16.58 21.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.047 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.695 ' CB ' HH11 ' A' ' 7' ' ' ARG . 0.0 OUTLIER -82.01 -48.32 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.592 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -51.09 -51.35 54.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.678 ' CG2' ' CE2' ' A' ' 13' ' ' PHE . 7.6 p -49.62 -47.37 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.432 HG22 ' HN2' ' A' ' 14' ' ' NH2 . 48.7 mm -44.69 -36.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -54.85 -35.87 64.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 9' ' ' VAL . 5.1 tmtm? -83.82 -30.08 26.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.291 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.784 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 32.5 p90 -174.2 95.92 0.09 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.315 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . 0.432 ' HN2' HG22 ' A' ' 10' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 120.001 -1.687 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.665 HH11 ' CG ' ' A' ' 1' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.604 ' C ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -48.82 -19.45 0.37 Allowed 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.845 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.584 ' N ' HD13 ' A' ' 2' ' ' LEU . 52.4 m-85 -86.29 -29.08 23.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.082 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 1' ' ' ARG . 14.6 m-20 -48.47 -21.79 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' N ' ' C ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -87.55 -30.88 20.21 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.898 179.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -74.3 -18.1 16.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.526 ' CG ' HH11 ' A' ' 7' ' ' ARG . 1.4 ttt-85 -83.87 -49.97 8.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.55 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -49.15 -48.29 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.805 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.607 ' CG2' ' CE1' ' A' ' 13' ' ' PHE . 7.2 p -51.14 -49.05 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 10' ' ' ILE . 47.6 mm -44.92 -32.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -56.23 -35.68 67.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 9' ' ' VAL . 57.4 tttp -86.46 -29.64 22.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.593 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.708 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 50.2 p90 -172.85 92.85 0.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.395 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . 0.452 ' HN2' HG23 ' A' ' 10' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.358 0 O-C-N 119.978 -1.702 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.654 HH11 ' CG ' ' A' ' 1' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.622 HD11 ' N ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -55.62 -20.52 14.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.06 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.622 ' N ' HD11 ' A' ' 2' ' ' LEU . 51.0 m-85 -86.52 -28.14 23.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.306 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.28 -21.19 1.28 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 3' ' ' PHE . 23.1 ttmt -87.54 -25.15 23.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.909 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -85.54 -20.27 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.244 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.17 -42.7 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.881 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -61.65 -41.14 97.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.489 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 12' ' ' LYS . 7.4 p -56.94 -50.42 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.159 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 13' ' ' PHE . 1.5 mp -44.99 -36.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.256 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -52.73 -30.71 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.664 ' N ' ' O ' ' A' ' 9' ' ' VAL . 29.7 ttmt -88.03 -29.57 20.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.347 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.704 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 54.9 p90 -171.72 94.03 0.15 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.506 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.394 0 O-C-N 119.919 -1.738 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.427 ' C ' ' N ' ' A' ' 3' ' ' PHE . 26.5 ptt180 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.616 ' C ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -47.54 -17.69 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.058 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 6' ' ' ILE . 57.9 m-85 -85.84 -29.5 23.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.495 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -21.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' N ' ' C ' ' A' ' 3' ' ' PHE . 38.4 tttm -87.53 -29.7 21.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.833 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.57 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -78.91 -24.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.168 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -83.77 -51.43 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.472 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -48.04 -46.7 33.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.794 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.568 ' CG2' ' CE1' ' A' ' 13' ' ' PHE . 7.9 p -51.34 -50.02 29.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.727 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.469 HG21 ' HN2' ' A' ' 14' ' ' NH2 . 45.2 mm -44.85 -35.06 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.529 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -54.23 -36.42 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 9' ' ' VAL . 27.3 ttpt -86.79 -28.17 23.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.62 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.728 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 46.9 p90 -174.85 93.22 0.07 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.456 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . 0.469 ' HN2' HG21 ' A' ' 10' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 120.028 -1.67 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 4' ' ' ASP . 2.7 tpt180 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.613 ' C ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -45.83 -20.46 0.08 Allowed 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.698 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.578 ' N ' HD11 ' A' ' 2' ' ' LEU . 53.0 m-85 -86.44 -28.12 23.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.948 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 1' ' ' ARG . 19.1 m-20 -50.55 -19.95 1.04 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' N ' ' C ' ' A' ' 3' ' ' PHE . 29.5 ttmt -87.52 -28.64 21.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.454 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -83.59 -25.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.135 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.668 ' CG ' HH11 ' A' ' 7' ' ' ARG . 0.3 OUTLIER -83.6 -52.39 6.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -49.26 -46.55 46.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.883 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.63 ' CG2' ' CZ ' ' A' ' 13' ' ' PHE . 11.2 p -50.0 -48.81 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.489 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.467 ' HA ' ' C ' ' A' ' 13' ' ' PHE . 38.5 mm -46.91 -39.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -53.26 -33.39 52.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' VAL . 28.5 tttm -87.33 -28.95 21.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.354 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 54.9 p90 -177.57 94.54 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.477 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . 0.437 ' HN2' HG23 ' A' ' 10' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.35 0 O-C-N 120.011 -1.681 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.901 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 2' ' ' LEU . 56.8 m-85 -85.35 -29.33 24.56 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.976 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -47.44 -22.54 0.46 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.447 ' N ' ' C ' ' A' ' 3' ' ' PHE . 17.8 ttmt -87.48 -34.67 18.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.842 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -67.94 -16.58 21.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.047 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.718 ' CB ' HH11 ' A' ' 7' ' ' ARG . 0.0 OUTLIER -82.01 -48.32 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.592 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -51.09 -51.35 54.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.678 ' CG2' ' CE2' ' A' ' 13' ' ' PHE . 7.6 p -49.62 -47.37 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' N ' HG13 ' A' ' 9' ' ' VAL . 48.7 mm -44.69 -36.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -54.85 -35.87 64.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 9' ' ' VAL . 5.1 tmtm? -83.82 -30.08 26.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.291 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.784 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 32.5 p90 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.315 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.902 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.434 0 CA-C-O 120.775 0.321 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 2' ' ' LEU . 52.4 m-85 -86.29 -29.08 23.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.082 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -48.47 -21.79 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.458 ' N ' ' C ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -87.55 -30.88 20.21 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.898 179.282 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -74.3 -18.1 16.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.534 ' CG ' HH11 ' A' ' 7' ' ' ARG . 1.4 ttt-85 -83.87 -49.97 8.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.55 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -49.15 -48.29 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.805 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 10' ' ' ILE . 7.2 p -51.14 -49.05 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.618 ' N ' HG13 ' A' ' 9' ' ' VAL . 47.6 mm -44.92 -32.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -56.23 -35.68 67.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 9' ' ' VAL . 57.4 tttp -86.46 -29.64 22.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.593 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.708 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 50.2 p90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.395 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.91 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.377 0 CA-C-O 120.576 0.227 . . . . 0.0 111.06 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.727 ' CD2' HD11 ' A' ' 2' ' ' LEU . 51.0 m-85 -86.52 -28.14 23.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.306 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.28 -21.19 1.28 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 3' ' ' PHE . 23.1 ttmt -87.54 -25.15 23.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.909 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -85.54 -20.27 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.244 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.17 -42.7 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.881 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -61.65 -41.14 97.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.489 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 12' ' ' LYS . 7.4 p -56.94 -50.42 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.159 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.608 ' N ' HG13 ' A' ' 9' ' ' VAL . 1.5 mp -44.99 -36.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.256 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -52.73 -30.71 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.664 ' N ' ' O ' ' A' ' 9' ' ' VAL . 29.7 ttmt -88.03 -29.57 20.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.347 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.704 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 54.9 p90 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.506 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.905 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.442 0 CA-C-O 120.672 0.272 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CE2' HD11 ' A' ' 2' ' ' LEU . 57.9 m-85 -85.84 -29.5 23.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.495 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -21.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.472 ' N ' ' C ' ' A' ' 3' ' ' PHE . 38.4 tttm -87.53 -29.7 21.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.833 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -78.91 -24.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.168 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -83.77 -51.43 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.472 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -48.04 -46.7 33.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.794 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.667 HG13 ' N ' ' A' ' 10' ' ' ILE . 7.9 p -51.34 -50.02 29.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.727 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.667 ' N ' HG13 ' A' ' 9' ' ' VAL . 45.2 mm -44.85 -35.06 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.529 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -54.23 -36.42 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 9' ' ' VAL . 27.3 ttpt -86.79 -28.17 23.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.62 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.728 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 46.9 p90 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.456 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.914 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.465 0 CA-C-O 120.744 0.307 . . . . 0.0 110.698 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.686 ' CD2' HD11 ' A' ' 2' ' ' LEU . 53.0 m-85 -86.44 -28.12 23.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.948 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -50.55 -19.95 1.04 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.46 ' N ' ' C ' ' A' ' 3' ' ' PHE . 29.5 ttmt -87.52 -28.64 21.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.454 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -83.59 -25.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.135 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.68 ' CG ' HH11 ' A' ' 7' ' ' ARG . 0.3 OUTLIER -83.6 -52.39 6.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -49.26 -46.55 46.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.883 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 10' ' ' ILE . 11.2 p -50.0 -48.81 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.489 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.646 ' N ' HG13 ' A' ' 9' ' ' VAL . 38.5 mm -46.91 -39.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -53.26 -33.39 52.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' VAL . 28.5 tttm -87.33 -28.95 21.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.354 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 54.9 p90 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.477 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 4' ' ' ASP . 12.9 mmt180 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.901 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -46.07 -17.4 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 2' ' ' LEU . 56.8 m-85 -85.35 -29.33 24.56 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.976 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 1' ' ' ARG . 41.7 m-20 -47.44 -22.54 0.46 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' N ' ' C ' ' A' ' 3' ' ' PHE . 17.8 ttmt -87.48 -34.67 18.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.842 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -67.94 -16.58 21.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.047 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.718 ' CB ' HH11 ' A' ' 7' ' ' ARG . 0.0 OUTLIER -82.01 -48.32 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.592 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -51.09 -51.35 54.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.678 ' CG2' ' CE2' ' A' ' 13' ' ' PHE . 7.6 p -49.62 -47.37 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' N ' HG13 ' A' ' 9' ' ' VAL . 48.7 mm -44.69 -36.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -54.85 -35.87 64.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 9' ' ' VAL . 5.1 tmtm? -83.82 -30.08 26.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.291 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.784 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 32.5 p90 -174.2 95.92 0.09 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.315 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 120.001 -1.687 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.677 HH11 ' CG ' ' A' ' 1' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.902 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -48.82 -19.45 0.37 Allowed 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.845 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 2' ' ' LEU . 52.4 m-85 -86.29 -29.08 23.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.082 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 1' ' ' ARG . 14.6 m-20 -48.47 -21.79 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' N ' ' C ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -87.55 -30.88 20.21 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.898 179.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -74.3 -18.1 16.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.534 ' CG ' HH11 ' A' ' 7' ' ' ARG . 1.4 ttt-85 -83.87 -49.97 8.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.55 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -49.15 -48.29 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.805 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 10' ' ' ILE . 7.2 p -51.14 -49.05 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.618 ' N ' HG13 ' A' ' 9' ' ' VAL . 47.6 mm -44.92 -32.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -56.23 -35.68 67.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 9' ' ' VAL . 57.4 tttp -86.46 -29.64 22.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.593 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.708 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 50.2 p90 -172.85 92.85 0.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.395 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 O-C-N 119.978 -1.702 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.67 HH11 ' CG ' ' A' ' 1' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.91 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -55.62 -20.52 14.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.06 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.727 ' CD2' HD11 ' A' ' 2' ' ' LEU . 51.0 m-85 -86.52 -28.14 23.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.306 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.28 -21.19 1.28 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 3' ' ' PHE . 23.1 ttmt -87.54 -25.15 23.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.909 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -85.54 -20.27 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.244 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.17 -42.7 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.881 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -61.65 -41.14 97.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.489 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 12' ' ' LYS . 7.4 p -56.94 -50.42 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.159 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.608 ' N ' HG13 ' A' ' 9' ' ' VAL . 1.5 mp -44.99 -36.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.256 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -52.73 -30.71 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.664 ' N ' ' O ' ' A' ' 9' ' ' VAL . 29.7 ttmt -88.03 -29.57 20.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.347 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.704 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 54.9 p90 -171.72 94.03 0.15 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.506 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.394 0 O-C-N 119.919 -1.738 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.427 ' C ' ' N ' ' A' ' 3' ' ' PHE . 26.5 ptt180 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.905 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -47.54 -17.69 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.058 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CE2' HD11 ' A' ' 2' ' ' LEU . 57.9 m-85 -85.84 -29.5 23.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.495 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -21.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' N ' ' C ' ' A' ' 3' ' ' PHE . 38.4 tttm -87.53 -29.7 21.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.833 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -78.91 -24.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.168 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -83.77 -51.43 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.472 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -48.04 -46.7 33.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.794 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.667 HG13 ' N ' ' A' ' 10' ' ' ILE . 7.9 p -51.34 -50.02 29.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.727 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.667 ' N ' HG13 ' A' ' 9' ' ' VAL . 45.2 mm -44.85 -35.06 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.529 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -54.23 -36.42 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 9' ' ' VAL . 27.3 ttpt -86.79 -28.17 23.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.62 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.728 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 46.9 p90 -174.85 93.22 0.07 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.456 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 120.028 -1.67 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 4' ' ' ASP . 2.7 tpt180 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.914 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -45.83 -20.46 0.08 Allowed 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.698 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.686 ' CD2' HD11 ' A' ' 2' ' ' LEU . 53.0 m-85 -86.44 -28.12 23.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.948 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 1' ' ' ARG . 19.1 m-20 -50.55 -19.95 1.04 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' N ' ' C ' ' A' ' 3' ' ' PHE . 29.5 ttmt -87.52 -28.64 21.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.454 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -83.59 -25.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.135 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.68 ' CG ' HH11 ' A' ' 7' ' ' ARG . 0.3 OUTLIER -83.6 -52.39 6.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -49.26 -46.55 46.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.883 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 10' ' ' ILE . 11.2 p -50.0 -48.81 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.489 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.646 ' N ' HG13 ' A' ' 9' ' ' VAL . 38.5 mm -46.91 -39.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -53.26 -33.39 52.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' VAL . 28.5 tttm -87.33 -28.95 21.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.354 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 54.9 p90 -177.57 94.54 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.477 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.35 0 O-C-N 120.011 -1.681 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.901 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 2' ' ' LEU . 56.8 m-85 -85.35 -29.33 24.56 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.976 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -47.44 -22.54 0.46 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.447 ' N ' ' C ' ' A' ' 3' ' ' PHE . 17.8 ttmt -87.48 -34.67 18.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.842 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -67.94 -16.58 21.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.047 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.718 ' CB ' HH11 ' A' ' 7' ' ' ARG . 0.0 OUTLIER -82.01 -48.32 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.592 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -51.09 -51.35 54.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.678 ' CG2' ' CE2' ' A' ' 13' ' ' PHE . 7.6 p -49.62 -47.37 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' N ' HG13 ' A' ' 9' ' ' VAL . 48.7 mm -44.69 -36.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -54.85 -35.87 64.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 9' ' ' VAL . 5.1 tmtm? -83.82 -30.08 26.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.291 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.784 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 32.5 p90 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.315 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.902 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.434 0 CA-C-O 120.775 0.321 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 2' ' ' LEU . 52.4 m-85 -86.29 -29.08 23.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.082 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -48.47 -21.79 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.458 ' N ' ' C ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -87.55 -30.88 20.21 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.898 179.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -74.3 -18.1 16.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.534 HH11 ' CG ' ' A' ' 7' ' ' ARG . 1.4 ttt-85 -83.87 -49.97 8.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.55 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -49.15 -48.29 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.805 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 10' ' ' ILE . 7.2 p -51.14 -49.05 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.618 ' N ' HG13 ' A' ' 9' ' ' VAL . 47.6 mm -44.92 -32.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -56.23 -35.68 67.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 9' ' ' VAL . 57.4 tttp -86.46 -29.64 22.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.593 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.708 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 50.2 p90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.395 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.91 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.377 0 CA-C-O 120.576 0.227 . . . . 0.0 111.06 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.727 ' CD2' HD11 ' A' ' 2' ' ' LEU . 51.0 m-85 -86.52 -28.14 23.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.306 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.28 -21.19 1.28 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 3' ' ' PHE . 23.1 ttmt -87.54 -25.15 23.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.909 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -85.54 -20.27 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.244 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.17 -42.7 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.881 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -61.65 -41.14 97.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.489 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 12' ' ' LYS . 7.4 p -56.94 -50.42 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.159 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.608 ' N ' HG13 ' A' ' 9' ' ' VAL . 1.5 mp -44.99 -36.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.256 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -52.73 -30.71 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.664 ' N ' ' O ' ' A' ' 9' ' ' VAL . 29.7 ttmt -88.03 -29.57 20.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.347 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.704 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 54.9 p90 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.506 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.905 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.442 0 CA-C-O 120.672 0.272 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CE2' HD11 ' A' ' 2' ' ' LEU . 57.9 m-85 -85.84 -29.5 23.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.495 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -21.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.472 ' N ' ' C ' ' A' ' 3' ' ' PHE . 38.4 tttm -87.53 -29.7 21.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.833 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -78.91 -24.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.168 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -83.77 -51.43 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.472 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -48.04 -46.7 33.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.794 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.667 HG13 ' N ' ' A' ' 10' ' ' ILE . 7.9 p -51.34 -50.02 29.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.727 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.667 ' N ' HG13 ' A' ' 9' ' ' VAL . 45.2 mm -44.85 -35.06 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.529 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -54.23 -36.42 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 9' ' ' VAL . 27.3 ttpt -86.79 -28.17 23.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.62 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.728 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 46.9 p90 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.456 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.914 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.465 0 CA-C-O 120.744 0.307 . . . . 0.0 110.698 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.686 ' CD2' HD11 ' A' ' 2' ' ' LEU . 53.0 m-85 -86.44 -28.12 23.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.948 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -50.55 -19.95 1.04 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.46 ' N ' ' C ' ' A' ' 3' ' ' PHE . 29.5 ttmt -87.52 -28.64 21.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.454 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -83.59 -25.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.135 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.68 HH11 ' CG ' ' A' ' 7' ' ' ARG . 0.3 OUTLIER -83.6 -52.39 6.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -49.26 -46.55 46.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.883 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 10' ' ' ILE . 11.2 p -50.0 -48.81 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.489 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.646 ' N ' HG13 ' A' ' 9' ' ' VAL . 38.5 mm -46.91 -39.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -53.26 -33.39 52.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' VAL . 28.5 tttm -87.33 -28.95 21.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.354 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.667 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 54.9 p90 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.477 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 4' ' ' ASP . 12.9 mmt180 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.901 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -46.07 -17.4 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 2' ' ' LEU . 56.8 m-85 -85.35 -29.33 24.56 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.976 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 1' ' ' ARG . 41.7 m-20 -47.44 -22.54 0.46 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' N ' ' C ' ' A' ' 3' ' ' PHE . 17.8 ttmt -87.48 -34.67 18.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.842 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -67.94 -16.58 21.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.047 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.718 ' CB ' HH11 ' A' ' 7' ' ' ARG . 0.0 OUTLIER -82.01 -48.32 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.592 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -51.09 -51.35 54.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.678 ' CG2' ' CE2' ' A' ' 13' ' ' PHE . 7.6 p -49.62 -47.37 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' N ' HG13 ' A' ' 9' ' ' VAL . 48.7 mm -44.69 -36.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -54.85 -35.87 64.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 9' ' ' VAL . 5.1 tmtm? -83.82 -30.08 26.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.291 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.784 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 32.5 p90 -174.2 95.92 0.09 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.315 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 120.001 -1.687 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.677 ' CG ' HH11 ' A' ' 1' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.902 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -48.82 -19.45 0.37 Allowed 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.845 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 2' ' ' LEU . 52.4 m-85 -86.29 -29.08 23.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.082 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 1' ' ' ARG . 14.6 m-20 -48.47 -21.79 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' N ' ' C ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -87.55 -30.88 20.21 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.898 179.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -74.3 -18.1 16.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.534 HH11 ' CG ' ' A' ' 7' ' ' ARG . 1.4 ttt-85 -83.87 -49.97 8.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.55 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -49.15 -48.29 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.805 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 10' ' ' ILE . 7.2 p -51.14 -49.05 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.618 ' N ' HG13 ' A' ' 9' ' ' VAL . 47.6 mm -44.92 -32.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -56.23 -35.68 67.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 9' ' ' VAL . 57.4 tttp -86.46 -29.64 22.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.593 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.708 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 50.2 p90 -172.85 92.85 0.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.395 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 O-C-N 119.978 -1.702 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.67 ' CG ' HH11 ' A' ' 1' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.91 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -55.62 -20.52 14.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.06 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.727 ' CD2' HD11 ' A' ' 2' ' ' LEU . 51.0 m-85 -86.52 -28.14 23.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.306 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.28 -21.19 1.28 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 3' ' ' PHE . 23.1 ttmt -87.54 -25.15 23.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.909 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -85.54 -20.27 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.244 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.17 -42.7 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.881 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -61.65 -41.14 97.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.489 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 12' ' ' LYS . 7.4 p -56.94 -50.42 75.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.159 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.608 ' N ' HG13 ' A' ' 9' ' ' VAL . 1.5 mp -44.99 -36.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.256 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -52.73 -30.71 34.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.664 ' N ' ' O ' ' A' ' 9' ' ' VAL . 29.7 ttmt -88.03 -29.57 20.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.347 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.704 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 54.9 p90 -171.72 94.03 0.15 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.506 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.394 0 O-C-N 119.919 -1.738 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.427 ' C ' ' N ' ' A' ' 3' ' ' PHE . 26.5 ptt180 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.905 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -47.54 -17.69 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.058 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CE2' HD11 ' A' ' 2' ' ' LEU . 57.9 m-85 -85.84 -29.5 23.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.495 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -21.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' N ' ' C ' ' A' ' 3' ' ' PHE . 38.4 tttm -87.53 -29.7 21.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.833 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.3 mp -78.91 -24.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.168 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -83.77 -51.43 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.472 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -48.04 -46.7 33.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.794 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.667 HG13 ' N ' ' A' ' 10' ' ' ILE . 7.9 p -51.34 -50.02 29.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.727 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.667 ' N ' HG13 ' A' ' 9' ' ' VAL . 45.2 mm -44.85 -35.06 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.529 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -54.23 -36.42 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 9' ' ' VAL . 27.3 ttpt -86.79 -28.17 23.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.62 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.728 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 46.9 p90 -174.85 93.22 0.07 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.456 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 120.028 -1.67 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 4' ' ' ASP . 2.7 tpt180 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.914 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -45.83 -20.46 0.08 Allowed 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.698 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.686 ' CD2' HD11 ' A' ' 2' ' ' LEU . 53.0 m-85 -86.44 -28.12 23.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.948 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 1' ' ' ARG . 19.1 m-20 -50.55 -19.95 1.04 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' N ' ' C ' ' A' ' 3' ' ' PHE . 29.5 ttmt -87.52 -28.64 21.89 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.454 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -83.59 -25.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.135 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.68 HH11 ' CG ' ' A' ' 7' ' ' ARG . 0.3 OUTLIER -83.6 -52.39 6.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -49.26 -46.55 46.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.883 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 10' ' ' ILE . 11.2 p -50.0 -48.81 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.489 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.646 ' N ' HG13 ' A' ' 9' ' ' VAL . 38.5 mm -46.91 -39.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -53.26 -33.39 52.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' VAL . 28.5 tttm -87.33 -28.95 21.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.354 177.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.667 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 54.9 p90 -177.57 94.54 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.477 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.35 0 O-C-N 120.011 -1.681 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_